Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells

被引:28
作者
Shammas, MA
Liu, XH
Gavory, G
Raney, KD
Balasubramanian, S
Reis, RJS
机构
[1] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA
[2] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[3] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[4] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA
基金
英国生物技术与生命科学研究理事会;
关键词
telomerase; telomere; cancer; cell proliferation; cell transformation;
D O I
10.1016/j.yexcr.2004.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomeres are believed to stabilize chromosomes through several mechanisms that are dependent upon specific DNA-DNA and protein-DNA interactions. Telomeres are maintained by the enzyme telomerase. Telomerase activity, which is below detectable level in almost all types of diploid cells, is re-activated in most immortal and cancer cells. For this study, we designed peptide nucleic acid (PNA) oligonucleotides targeted to the telomeric G-rich strand, and tested their efficacy to reverse the immortality of transformed human fibroblasts. Anti-telomere PNAs, transfected into human fibroblasts along with a selectable marker, resulted in a significant reduction in colony size and elicited cell death by apoptosis. This PNA inhibitor does not inhibit telomerase activity in vitro, suggesting a distinct cellular mechanism from known PNA inhibitors. A combination of this class of PNA inhibitor with a PNA that does block telomerase activity resulted in nearly complete inhibition of colony growth, induction of apoptosis, and an apparent reduction in telomere length. Each effect was greater than that evoked by either agent alone, indicating enhanced efficacy for therapeutic approaches that target multiple, distinct mechanism of telomere maintenance. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:204 / 214
页数:11
相关论文
共 47 条
[1]   TELOMERIC REPEAT FROM T-THERMOPHILA CROSS HYBRIDIZES WITH HUMAN TELOMERES [J].
ALLSHIRE, RC ;
GOSDEN, JR ;
CROSS, SH ;
CRANSTON, G ;
ROUT, D ;
SUGAWARA, N ;
SZOSTAK, JW ;
FANTES, PA ;
HASTIE, ND .
NATURE, 1988, 332 (6165) :656-659
[2]  
Avilion AA, 1996, CANCER RES, V56, P645
[3]   TELOMERASES [J].
BLACKBURN, EH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :113-129
[4]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[5]   TELOMERASE ACTIVITY IN NORMAL AND MALIGNANT HEMATOPOIETIC-CELLS [J].
BROCCOLI, D ;
YOUNG, JW ;
DELANGE, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9082-9086
[6]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274
[7]   p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis [J].
Chin, L ;
Artandi, SE ;
Shen, Q ;
Tam, A ;
Lee, SL ;
Gottlieb, GJ ;
Greider, CW ;
DePinho, RA .
CELL, 1999, 97 (04) :527-538
[8]   Mammalian telomeres and telomerase [J].
Collins, K .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (03) :378-383
[9]   Telomerase: An unusual target for cytotoxic agents [J].
Corey, DR .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (10) :957-960
[10]   TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY [J].
COUNTER, CM ;
AVILION, AA ;
LEFEUVRE, CE ;
STEWART, NG ;
GREIDER, CW ;
HARLEY, CB ;
BACCHETTI, S .
EMBO JOURNAL, 1992, 11 (05) :1921-1929